During the past decade, Tokyo headache clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo headache clinic" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo headache clinic" are "Migraine" (3 trials). Many other conditions were trialed in "Tokyo headache clinic" in a lesser frequency.

Most popular intervention types in "Tokyo headache clinic" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Eptinezumab" (1 trials), "Erenumab Dose 1" (1 trials), "Erenumab Dose 2" (1 trials) and "Erenumab Dose 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo headache clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo headache clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Tokyo headache clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo headache clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".